Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
IBIsaac B. HiltonADAnthony D’IppolitoCMChristopher M. VockleyPIPratiksha I. ThakoreGEGregory E. Crawford
Duke University · Duke Medical Center
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,864
total citations
- FWCI
- 100.88
- Percentile
- 100%
- References
- 60
Citations per year
Authors
7Topics & keywords
Topics
Keywords
- Enhancer
- Biology
- Acetyltransferase
- CRISPR
- Promoter
- Cas9
- Epigenome
- Histone acetyltransferase
No related works found for this paper.